BIOCELL2025，Vol.49Issue(8)：P.1449-1480,32.DOI:10.32604/biocell.2025.068034
Metronomic Chemotherapy Response in MDA-MB-231 Triple-Negative Breast Cancer Cells under Nicotine Exposure
Alejandro Javier Español 1Yamila Sanchez 2Sofia Volpi3
作者信息
- 1. Tumor Immunopharmacology Laboratory,Center of Pharmacological and Botanical Studies(CEFYBO)-National Council for Science and Technology(CONICET),University of Buenos Aires,Buenos Aires,C1121ABG,Argentina Second Department of Pharmacology,School of Medicine,University of Buenos Aires,Buenos Aires,C1121ABG,Argentina
- 2. Tumor Immunopharmacology Laboratory,Center of Pharmacological and Botanical Studies(CEFYBO)-National Council for Science and Technology(CONICET),University of Buenos Aires,Buenos Aires,C1121ABG,Argentina
- 3. Second Department of Pharmacology,School of Medicine,University of Buenos Aires,Buenos Aires,C1121ABG,Argentina
- 折叠
摘要
关键词
Metronomic chemotherapy/breast cancer/nicotine/cancer stem cells分类
医药卫生引用本文复制引用
Alejandro Javier Español,Yamila Sanchez,Sofia Volpi..Metronomic Chemotherapy Response in MDA-MB-231 Triple-Negative Breast Cancer Cells under Nicotine Exposure[J].BIOCELL,2025,49(8):P.1449-1480,32.基金项目
the National Agency for Scientific and Technological Promotion(ANPCyT)[2015-2396] （ANPCyT）
ORT Argentina’s 2021-2025 Scientific Research Internship Program. （）
